A literature review on the problem of treatment of exudative otitis media was performed. Exudative otitis media (EMI) is one of the most actively studied diseases of the middle ear in recent decades. Particular interest in this pathology is due to the variety of clinical manifestations of the disease, the duration of the course, the laboriousness of treatment, often resistance to standard therapy for otitis media, and a tendency to relapse. Clinical signs: the presence of exudate in the tympanic cavity, the absence of signs of acute inflammation and defect of the tympanic membrane. Modern medicine is considering many options for the treatment of exudative otitis media, up to the alternative of using hearing aids for patients with contraindications to other types of treatment. On the territory of the CIS, patients are prescribed medication or surgical treatment without active observation tactics, in most European countries and the United States, a wait-and see approach is used.
Exudative otitis media is a polyetiological disease, often caused by a combination of several causal factors. With tumors located near the pharyngeal opening of the auditory tube, early manifestations may be symptoms from the ear and auditory tube - the phenomenon of exudative otitis media.
In this article, we present the features of the clinical course of exudative otitis media in benign neoplasms of the nose, paranasal sinuses and nasopharynx.
Tuberculosis remains a global public health problem, especially in the South Aral Sea region. The COVID-19 pandemic has exacerbated the TB epidemiological situation in the region. Because of the violation of the regimen in 2020, there was a decrease in the incidence of tuberculosis by 27%, in the success of treatment by 3% and growth in number of violations of the treatment regimen by 1.8 times, compared to 2019. In order to improve the quality of controlled treatment of tuberculosis, patients during the COVID-19 pandemic, the implementation of a pilot project "treatment under video surveillance" (LVN) has been launched. Currently, this project includes 30 patients. It is necessary to conduct an in-depth analysis of the effectiveness of the implemented measures, including treatment under video surveillance.